Journal of Virology

BK Polyomavirus Requires the Mismatch Repair Pathway for DNA Damage Response Activation..  96:e0202821. 2022

Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.  96. 2022

Lentiviral Nef Proteins Differentially Govern the Establishment of Viral Latency.  96. 2022

Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4⁺ T Cell.  96. 2022

Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.  96. 2022

Human Cytomegalovirus Hijacks WD Repeat Domain 11 for Virion Assembly Compartment Formation and Virion Morphogenesis.  96. 2022

Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.  96. 2022

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.  96. 2022

Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.  96. 2022

A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.  95. 2021

Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.  95. 2021

Natural and recombinant SARS-CoV-2 isolates rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.  95. 2021

A naturally occurring polymorphism in the base of Sudan virus glycoprotein decreases glycoprotein stability in a species-dependent manner.  95. 2021

A novel strain-specific neutralizing epitope on glycoprotein H of human cytomegalovirus.  95. 2021

Elevated HIV infection of CD4 T cells in MRKAd5 vaccine recipients due to CD8 T cells targeting adapted epitopes.  95. 2021

NAP1L1 and NAP1L4 binding to hypervariable domain of Chikungunya Virus nsP3 protein is bivalent and requires phosphorylation.  95. 2021

Link between interleukin-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals.  95. 2021

Consequences of phosphorylation in a mononegavirales polymerase-cofactor system.  95. 2021

Generation and characterization of recombinant SARS-CoV-2 expressing reporter genes.  95. 2021

Localization of the WD repeat-containing protein 5 to the virion assembly compartment facilitates human cytomegalovirus assembly.  95. 2021

Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.  95. 2021

Dual pathways of human immunodeficiency virus type 1 envelope glycoprotein trafficking modulate the selective exclusion of uncleaved oligomers from virions.  95. 2021

Structure of nonstructural protein 1 from SARS-CoV-2.  95. 2021

Enterovirus infection induces massive recruitment of all isoforms of small cellular arf GTPases to the replication organelles.  95. 2021

Structural and functional characterization of host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.  95. 2021

Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.  94. 2020

Cell fusion induced by a fusion-active form of human cytomegalovirus glycoprotein B (gB) is inhibited by antibodies directed at antigenic domain 5 in the ectodomain of gB.  94. 2020

Hypervariable domain of nsP3 of eastern equine encephalitis virus is a critical determinant of viral virulence.  94. 2020

Better viral control despite higher CD4+ T cell activation during acute HIV-1 infection in Zambian women is linked to the sex hormone estradiol.  94. 2020

BPIFB3 regulates endoplasmic reticulum morphology to facilitate flavivirus replication.  94. 2020

Long-Acting bms-378806 analogues stabilize the state-1 conformation of the human immunodeficiency virus type 1 envelope glycoproteins.  94. 2020

Mutations in hypervariable domain of venezuelan equine encephalitis virus nsP3 protein differentially affect viral replication.  94. 2020

Cross-reactive CD8 T-cell responses elicited by adenovirus type 5-based HIV-1 vaccines contributed to early viral evolution in vaccine recipients who became infected.  94. 2020

The connector domain of vesicular stomatitis virus large protein interacts with the viral phosphoprotein.  94. 2020

Primary HIV-1 strains use nef to downmodulate HLA-E surface expression.  93. 2019

The guanine nucleotide exchange factor GBF1 participates in rotavirus replication.  93. 2019

BK Polyomavirus Activates the DNA Damage Response to Prolong S Phase.  93. 2019

Novel mutations in NSP2 abolish Chikungunya virus-induced transcriptional shutoff and make the virus less cytopathic without affecting its replication rates.  93. 2019

A redundant mechanism of recruitment underlies the remarkable plasticity of the requirement of poliovirus replication for the cellular ArfGEF GBF1.  93. 2019

Defining HIV-1 envelope N-glycan microdomains through site-specific heterogeneity profiles.  93. 2019

Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.  92. 2018

Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice..  92. 2018

Antisense-derived HIV-1 cryptic epitopes are not major drivers of viral evolution during the acute phase of infection.  92. 2018

Human cytomegalovirus immediate early 1 protein causes loss of SOX2 from neural progenitor cells by trapping unphosphorylated STAT3 in the nucleus.  92. 2018

Higher expectations for a vaccine to prevent congenital cytomegalovirus infection.  92. 2018

Multiple host factors interact with the hypervariable domain of chikungunya virus nsP3 and determine viral replication in cell-specific mode.  92. 2018

Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and antibody-dependent cellular cytotoxicity responses..  92. 2018

WDR5 facilitates human cytomegalovirus replication by promoting capsid nuclear egress.  92. 2018

Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge.  92. 2018

β-D-N ⁴ -Hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome.  92. 2018

Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication.  92. 2018

Sindbis virus infection causes cell death by NSP2-induced transcriptional shutoff or by Nsp3-dependent translational shutoff.  92. 2018

Potent in vivo NK cellmediated elimination of HIV-1-infected cells mobilized by a gp120-bispecific and hexavalent broadly neutralizing fusion protein.  91. 2017

Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, noninfectious vaccine against Ebola virus challenge in mice.  91. 2017

Congenital human cytomegalovirus infection and the enigma of maternal immunity.  91. 2017

Attachment and postattachment receptors important for hepatitis C virus infection and cell-to-cell transmission.  91. 2017

Hypervariable domain of eastern equine encephalitis virus nsP3 redundantly utilizes multiple cellular proteins for replication complex assembly.  91. 2017

Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.  91. 2017

Tumor necrosis factor alpha-induced recruitment of inflammatory mononuclear cells leads to inflammation and altered brain development in murine cytomegalovirusinfected newborn mice.  91. 2017

TIM-1 promotes hepatitis C virus cell attachment and infection.  91. 2017

φX174 procapsid assembly: Effects of an inhibitory external scaffolding protein and resistant coat proteins in vitro.  91. 2017

Superior efficacy of a human immunodeficiency virus vaccine combined with antiretroviral prevention in simian-human immunodeficiency virus-challenged nonhuman primates.  90:5315-5328. 2016

BPIFB6 regulates secretory pathway trafficking and enterovirus replication.  90:5098-5107. 2016

Characterization of simian immunodeficiency virus variants anatomically compartmentalized in plasma and milk in chronically infected African green monkeys.  90:8795-8808. 2016

Correction: Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection [Journal of Virology, 87, 20, (2013) (10968-10979)] doi: 10.1128/JVI.01120-13.  90:10431-10433. 2016

Dynamics and correlates of CD8 T-cell counts in Africans with primary human immunodeficiency virus type 1 infection.  90:10423-10430. 2016

Exploitation of interleukin-10 (IL-10) signaling pathways: Alternate roles of viral and cellular IL-10 in rhesus cytomegalovirus infection.  90:9920-9930. 2016

Structure and function of the N-terminal domain of the vesicular stomatitis virus RNA polymerase.  90:715-724. 2016

The SD1 subdomain of venezuelan equine encephalitis virus capsid protein plays a critical role in nucleocapsid and particle assembly.  90:2008-2020. 2016

Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines.  89:2301-2312. 2015

A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 Virus.  89:4655-4667. 2015

Association of HIV-1 envelope-specific breast milk IgA responses with reduced risk of postnatal mother-to-child transmission of HIV-1.  89:9952-9961. 2015

Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.  89:3846-3858. 2015

Comparative analysis of the glycosylation profiles of membrane-anchored HIV-1 envelope glycoprotein trimers and soluble gp140.  89:8245-8257. 2015

Emergence of highly pathogenic avian influenza A(H5N1) virus PB1-F2 variants and their virulence in BALB/c mice.  89:5835-5846. 2015

HIV-1 and morphine regulation of autophagy in microglia: Limited interactions in the context of HIV-1 infection and opioid abuse.  89:1024-1035. 2015

Human cytomegalovirus infection dysregulates the localization and stability of NICD1 and Jag1 in neural progenitor cells.  89:6792-6804. 2015

Identification of a neutralizing epitope within Antigenic domain 5 of glycoprotein B of human cytomegalovirus.  89:361-372. 2015

In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice.  89:6264-6274. 2015

MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.  89:1070-1082. 2015

Stable phenotypic changes of the host T cells are essential to the long-term stability of latent HIV-1 infection.  89:6656-6672. 2015

The acetyltransferase Tip60 is a critical regulator of the differentiation-dependent amplification of human papillomaviruses.  89:4668-4675. 2015

The serum very-low-density lipoprotein serves as a restriction factor against hepatitis C virus infection.  89:6782-6791. 2015

The vaginal acquisition and dissemination of HIV-1 infection in a novel transgenic mouse model is facilitated by coinfection with herpes simplex virus 2 and is inhibited by microbicide treatment.  89:9559-9570. 2015

Vaccine-derived neutralizing antibodies to the human cytomegalovirus gH/gL pentamer potently block primary cytotrophoblast infection.  89:11884-11898. 2015

Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.  89:71-82. 2015

Global panel of HIV-1 env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.  88:2489-2507. 2014

High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.  88:2025-2034. 2014

Interferon-stimulated poly(ADP-ribose) polymerases are potent inhibitors of cellular translation and virus replication.  88:2116-2130. 2014

Common mechanism for RNA encapsidation by negative-strand RNA viruses.  88:3766-3775. 2014

Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection.  88:7412-7425. 2014

HIV-1 envelope glycan moieties modulate HIV-1 transmission.  88:14258-14267. 2014

Higher-order structure of the rous sarcoma virus SP assembly domain.  88:5617-5629. 2014

Identification of nucleotide-level changes impacting gene content and genome evolution in orthopoxviruses.  88:13651-13668. 2014

Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals.  88:10259-10263. 2014

Influenza virus infectivity and virulence following ocular-only aerosol inoculation of ferrets.  88:9647-9654. 2014

Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.  88:364-376. 2014

Rewiring of cellular membrane homeostasis by picornaviruses.  88:9478-9489. 2014

The 5' untranslated region of the human T-cell lymphotropic virus type 1 mRNA enables cap-independent translation initiation.  88:5936-5955. 2014

Vaginal myeloid dendritic cells transmit founder HIV-1.  88:7683-7688. 2014

Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.  87:13480-13489. 2013

Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques.  87:10447-10459. 2013

Vaccination against a virus-encoded cytokine significantly restricts viral challenge.  87:11323-11331. 2013

N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.  87:8756-8766. 2013

Thiouracil cross-linking mass spectrometry: A cell-based method to identify host factors involved in viral amplification.  87:8697-8712. 2013

Comparison of the levels of infectious virus in respirable aerosols exhaled by ferrets infected with influenza viruses exhibiting diverse transmissibility phenotypes.  87:7864-7873. 2013

Hypervariable domain of nonstructural protein nsp3 of venezuelan equine encephalitis virus determines cell-specific mode of virus replication.  87:7569-7584. 2013

Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees.  87:7828-7836. 2013

Structural and functional characterization of the mumps virus phosphoprotein.  87:7558-7568. 2013

Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine.  87:6127-6136. 2013

Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.  87:6866-6875. 2013

HIV-specific CD8⁺ T cells from elite controllers are primed for survival.  87:5170-5181. 2013

Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis.  87:5746-5754. 2013

HLA-B*57 versus HLA-B*81 in HIV-1 infection: Slow and steady wins the race?.  87:4043-4051. 2013

Venezuelan equine encephalitis virus nsP2 protein regulates packaging of the viral genome into infectious virions.  87:4202-4213. 2013

An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.  87:2264-2277. 2013

Hypervariable Domains of nsP3 Proteins of New World and Old World Alphaviruses Mediate Formation of Distinct, Virus-Specific Protein Complexes.  87:1997-2010. 2013

Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.  87:708-715. 2013

Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection.  87:10968-10979. 2013

Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.  87:890-899. 2013

Pseudoinfectious Venezuelan Equine Encephalitis Virus: A New Means of Alphavirus Attenuation.  87:2023-2035. 2013

Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza a (H3N2v) virus in ferrets.  87:1261-1263. 2013

The amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains.  87:12003-12019. 2013

Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures.  87:2597-2607. 2013

Deletion of specific immune-modulatory genes from modified vaccinia virus ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.  86:12605-12615. 2012

TLR7 Recognition is dispensable for influenza virus a infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.  86:10988-10998. 2012

oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza a virus.  86:10924-10934. 2012

Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus..  86:8987-8997. 2012

Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.  86:9055-9069. 2012

New PARP gene with an anti-alphavirus function.  86:8147-8160. 2012

Antibody-dependent cellular cytotoxicity against primary hivinfected CD4 ⁺ T cells is directly associated with the magnitude of surface igg binding.  86:8672-8680. 2012

Evasion of the innate immune response: The old world alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II.  86:7180-7191. 2012

Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate..  86:7256-7267. 2012

Initial HIV-1 antigen-specific CD8⁺ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.  86:6835-6846. 2012

Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.  86:7118-7125. 2012

Early events in alphavirus replication determine the outcome of infection.  86:5055-5066. 2012

Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.  86:5304-5313. 2012

Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.  86:4548-4558. 2012

Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.  86:4234-4244. 2012

Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.  86:2715-2728. 2012

Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis.  86:11-18. 2012

Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: Possible involvement in the pathogenesis of human H5N1 virus infection.  86:667-678. 2012

Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.  85:11196-11207. 2011

Ocular tropism of influenza a viruses: Identification of H7 subtype-specific host responses in human respiratory and ocular cells.  85:10117-10125. 2011

Chimeric chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.  85:9249-9252. 2011

Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.  85:8894-8902. 2011

Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution..  85:8022-8036. 2011

Construction of a full transcription map of human papillomavirus type 18 during productive viral infection..  85:8080-8092. 2011

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.  85:7029-7036. 2011

Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.  85:5546-5554. 2011

A role for the small GTPase Rab6 in assembly of human cytomegalovirus.  85:5213-5219. 2011

Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.  85:4363-4376. 2011

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.  85:5027-5035. 2011

Access to RNA encapsidated in the nucleocapsid of vesicular stomatitis virus.  85:2714-2722. 2011

Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers.  85:2316-2324. 2011

The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells (Journal of Virology (2005) 79, 4, (2261-2273)).  85:3041. 2011

Viral exploitation of host SOCS protein functions.  85:1912-1921. 2011

Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic.  85:1563-1572. 2011

Conservation of a packaging signal and the Vira genome RNA packaging mechanism in alphavirus evolution.  85:8022-8036. 2011

Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.  85:8080-8092. 2011

Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: Kinetics from epithelial cell culture and computational modeling.  85:1125-1135. 2011

The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.  85:686-696. 2011

Immature and Transitional B Cells Are Latency Reservoirs for a Gammaherpesvirus.  84:13045-13052. 2010

NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)..  84:12733-12753. 2010

Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA.  84:12325-12335. 2010

Functional sindbis virus replicative complexes are formed at the plasma membrane.  84:11679-11695. 2010

The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus..  84:11532-11541. 2010

Crystallographic structure of porcine adenovirus type 4 fiber head and galectin domains.  84:10558-10568. 2010

Hit-and-run stimulation: A novel concept to reactivate latent HIV-1 infection without cytokine gene induction.  84:8712-8720. 2010

Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.  84:7613-7624. 2010

Use of a Virus-Encoded Enzymatic Marker Reveals that a Stable Fraction of Memory B Cells Expresses Latency-Associated Nuclear Antigen throughout Chronic Gammaherpesvirus Infection.  84:7523-7534. 2010

Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132.  84:7039-7052. 2010

Wide variation in the multiplicity of HIV-1 infection among injection drug users.  84:6241-6247. 2010

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.  84:4194-4203. 2010

Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.  84:4998-5006. 2010

Venezuelan equine encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin α/β that obstructs nuclear pore complex function.  84:4158-4171. 2010

Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells.  84:3162-3177. 2010

Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.  84:2610-2617. 2010

Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.  84:10004-10015. 2010

Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.  84:503-515. 2010

Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles..  83:12680-12691. 2009

Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway.  83:13026-13031. 2009

Characterization of a mumps virus nucleocapsidlike particle.  83:11402-11406. 2009

Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human t cells.  83:11283-11297. 2009

Structural and functional elements of the promoter encoded by the 5′ untranslated region of the Venezuelan equine encephalitis virus genome.  83:8327-8339. 2009

Random insertion mutagenesis of sindbis virus nonstructural protein 2 and selection of variants incapable of downregulating cellular transcription.  83:9031-9044. 2009

Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: A public health risk assessment.  83:8131-8140. 2009

Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters.  83:8182-8190. 2009

Ocular infection of mice with influenza A (H7) viruses: A site of primary replication and spread to the respiratory tract.  83:7075-7084. 2009

Early control of H5N1 influenza virus replication by the type I interferon response in mice.  83:5825-5834. 2009

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.  83:5726-5734. 2009

Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency.  83:3078-3093. 2009

Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection.  83:3258-3267. 2009

Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: Antiviral potential of exogenous alpha interferon to reduce virus shedding.  83:2851-2861. 2009

Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma.  83:1240-1259. 2009

Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice.  82:12172-12180. 2008

Structural Determinant of Human La Protein Critical for Internal Initiation of Translation of Hepatitis C Virus RNA.  82:11927-11938. 2008

Different types of nsP3-containing protein complexes in sindbis virus-infected cells.  82:10088-10101. 2008

The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.  82:10271-10278. 2008

Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase.  82:9228-9235. 2008

A new role for ns polyprotein cleavage in Sindbis virus replication.  82:6218-6231. 2008

Identification of mutated cyclization sequences that permit efficient replication of West Nile virus genomes: Use in safer propagation of a novel vaccine candidate.  82:6942-6951. 2008

Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration.  82:6458-6469. 2008

Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus.  82:6272-6287. 2008

Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for Cdc2.  82:5672-5682. 2008

Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.  82:4862-4873. 2008

Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.  82:5054-5067. 2008

Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice.  82:5079-5083. 2008

Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence.  82:4920-4930. 2008

Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection.  82:3295-3310. 2008

Venezuelan equine encephalitis virus capsid protein inhibits nuclear import in mammalian but not in mosquito cells.  82:4028-4041. 2008

Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted gag epitope in chronic human immunodeficiency virus type 1 infection (Journal of Virology (2007) 81, 15, (8346-8351)).  82:3161. 2008

Role of intermolecular interactions of vesicular stomatitis virus nucleoprotein in RNA encapsidation.  82:674-682. 2008

Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.  81:13552-13565. 2007

Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture..  81:13783-13793. 2007

Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.  81:12608-12618. 2007

Estimating the effectiveness of simian immunodeficiency virus-specific CD8⁺ T cells from the dynamics of viral immune escape.  81:11982-11991. 2007

Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells.  81:12439-12449. 2007

Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.  81:12071-12076. 2007

Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter.  81:11730-11736. 2007

Production of pseudoinfectious yellow fever virus with a two-component genome.  81:11737-11748. 2007

Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus.  81:11722-11729. 2007

Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.  81:10869-10878. 2007

Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: Enhanced virulence of eurasian H7N7 viruses isolated from humans.  81:11139-11147. 2007

The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses.  81:10818-10821. 2007

The cytoplasmic tail of glycoprotein M (gpUL100) expresses trafficking signals required for human cytomegalovirus assembly and replication.  81:10316-10328. 2007

Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire.  81:9331-9338. 2007

Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted gag epitope in chronic human immunodeficiency virus type 1 infection.  81:8346-8351. 2007

Dynein-dependent transport of the Hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment.  81:8634-8647. 2007

Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.  81:7238-7248. 2007

Cytoplasmic envelopment of human cytomegalovirus requires the postlocalization function of tegument protein pp28 within the assembly compartment.  81:6536-6547. 2007

Human serum amyloid A protein inhibits hepatitis C virus entry into cells..  81:6128-6133. 2007

Development of Sindbis viruses encoding nsP2/GFP chimeric proteins and their application for studying nsP2 functioning.  81:5046-5057. 2007

Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import.  81:5066-5078. 2007

Novel nuclear import of Vpr promoted by importin a is crucial for human immunodeficiency virus type 1 replication in macrophages.  81:5284-5293. 2007

The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.  81:5212-5224. 2007

Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: Implications for clinical efficacy.  81:3272-3284. 2007

Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.  81:4348-4356. 2007

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.  81:2736-2744. 2007

The old world and new world alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.  81:2472-2484. 2007

Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.  81:1619-1631. 2007

Notch1 augments intracellular trafficking of adeno-associated virus type 2.  81:2069-2073. 2007

The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.  80:10675-10682. 2006

Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli tRNA3^Lys supplied in trans.  80:9641-9650. 2006

Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.  80:8469-8481. 2006

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.  80:8909-8919. 2006

Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus Ankara enhances antiviral cellular and humoral immune responses.  80:7676-7687. 2006

Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities..  80:7364-7374. 2006

Serial passage through human glioma xenografts selects for a Δγ134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors.  80:7308-7315. 2006

Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.  80:6517-6524. 2006

Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles.  80:5886-5896. 2006

Human cytomegalovirus attenuates interleukin-1β and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-κB activation.  80:5588-5598. 2006

Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans.  80:6056-6060. 2006

Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus.  80:5611-5626. 2006

Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription.  80:5686-5696. 2006

Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.  80:4792-4800. 2006

Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.  80:4591-4600. 2006

Formation of nsP3-specific protein complexes during Sindbis virus replication.  80:4122-4134. 2006

Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4⁺ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.  80:3732-3742. 2006

Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus.  80:2808-2814. 2006

Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: Effects of highly active antiretroviral therapy provide insights into the mechanisms of naïve T-cell depletion.  80:2665-2674. 2006

Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.  80:2784-2796. 2006

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.  80:1959-1964. 2006

Human cytomegalovirus UL97 kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.  79:15494-15502. 2005

Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.  79:14933-14944. 2005

Herpes simplex virus type 1 glycoprotein E is required for axonal localization of capsid, tegument, and membrane glycoproteins.  79:13362-13372. 2005

Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells..  79:13963-13973. 2005

Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses.  79:12703-12713. 2005

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals.  79:11788-11800. 2005

Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts.  79:11837-11847. 2005

Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase..  79:11607-11617. 2005

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.  79:10108-10125. 2005

Inhibition of transcription and translation in Sindbis virus-infected cells.  79:9397-9409. 2005

Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase..  79:8687-8697. 2005

Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells.  79:7597-7608. 2005

Structural elements of the tRNA TψC loop critical for nucleocytoplasmic transport are important for human immunodeficiency virus type 1 primer selection.  79:6532-6539. 2005

Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.  79:4066-4079. 2005

Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts.  79:4043-4054. 2005

Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001.  79:4201-4212. 2005

Characterization of highly pathogenic H5N1 avian influenza a viruses isolated from South Korea.  79:3692-3702. 2005

Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication.  79:3231-3242. 2005

Importin-α promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr.  79:3557-3564. 2005

Complex formation by glycoproteins M and N of human cytomegalovirus: Structural and functional aspects.  79:2160-2170. 2005

The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells.  79:2261-2273. 2005

Diabetes acceleration or prevention by a coxsackievirus B4 infection: Critical requirements for both interleukin-4 and gamma interferon.  79:1045-1052. 2005

Productive replication of human adenovirus type 5 in canine cells.  79:1308-1311. 2005

Sindbis virus with a tricomponent genome.  79:637-643. 2005

Three-dimensional localization of the smallest capsid protein in the human cytomegalovirus capsid.  79:1327-1332. 2005

Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase.  78:13954-13965. 2004

Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNA.  78:14033-14038. 2004

Erratum: Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome (Journal of Virology (2004) 78:20 (10960-10966)).  78:13395. 2004

Evidence and consequence of porcine endogenous retrovirus recombination.  78:13880-13890. 2004

Experimental infection of NOD/SCID mice reconstituted with human CD34 ⁺ cells with Epstein-Barr virus.  78:13891-13900. 2004

Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.  78:14003-14011. 2004

Clonal selection for transcriptionally active viral oncogenes during progression to cancer.  78:11172-11186. 2004

Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.  78:11219-11232. 2004

Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome.  78:10960-10966. 2004

Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.  78:9041-9050. 2004

Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.  78:8573-8581. 2004

Increased levels of Wee-1 kinase in G2 are necessary for Vpr- and gamma irradiation-induced G2 arrest.  78:8183-8190. 2004

PKR-dependent and -independent mechanisms are involved in translational shutoff during sindbis virus infection.  78:8455-8467. 2004

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.  78:7217-7226. 2004

Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.  78:7089-7096. 2004

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.  78:6595-6609. 2004

Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus.  78:6688-6691. 2004

An Early Stage of Mason-Pfizer Monkey Virus Budding Is Regulated by the Hydrophobicity of the Gag Matrix Domain Core.  78:5023-5031. 2004

Changes of the Secondary Structure of the 5′ End of the Sindbis Virus Genome Inhibit Virus Growth in Mosquito Cells and Lead to Accumulation of Adaptive Mutations.  78:4953-4964. 2004

Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection.  78:4866-4875. 2004

Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell..  78:3633-3643. 2004

Impact of Human Cytomegalovirus Latent Infection on Myeloid Progenitor Cell Gene Expression.  78:4054-4062. 2004

Recombinant Modified Vaccinia Virus Ankara Expressing A Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus.  78:3965-3976. 2004

Analysis of the 3′ cis-Acting Elements of Rubella Virus by Using Replicons Expressing A Puromycin Resistance Gene.  78:2553-2561. 2004

Uncleaved NS2-3 Is Required for Production of Infectious Bovine Viral Diarrhea Virus.  78:2414-2425. 2004

Small Internal Deletions in the Human Cytomegalovirus IE2 Gene Result in Nonviable Recombinant Viruses with Differential Defects in Viral Gene Expression.  78:1817-1830. 2004

Phosphorylation of Human Cytomegalovirus Glycoprotein B (gB) at the Acidic Cluster Casein Kinase 2 Site (Ser900) Is Required for Localization of gB to the trans-Golgi Network and Efficient Virus Replication.  78:285-293. 2004

Rapid Genetic Engineering of Human Cytomegalovirus by Using a Lambda Phage Linear Recombination System: Demonstration that pp28 (UL99) Is Essential for Production of Infectious Virus.  78:539-543. 2004

Selection of Functional 5′ cis-Acting Elements Promoting Efficient Sindbis Virus Genome Replication.  78:61-75. 2004

The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome Persistence.  78:294-301. 2004

Mechanisms Governing Maintenance of Cdk1/Cyclin B1 Kinase Activity in Cells Infected with Human Cytomegalovirus.  77:13214-13224. 2003

Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): Naturally selected mutations in IN augment DNA synthesis.  77:11050-11059. 2003

mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.  77:10213-10226. 2003

Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.  77:9278-9286. 2003

Probing the importance of tRNA anticodon: Human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA^Glu for replication.  77:8756-8764. 2003

Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis.  77:8695-8701. 2003

Delivery of adeno-associated virus vectors to the fetal retina: Impact of viral capsid proteins on retinal neuronal progenitor transduction.  77:7957-7963. 2003

Erratum: Envelopment of human cytomegalovirus occurs by budding into golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II (Journal of Virology (2003) 77:5 (3191-3203)).  77:8179. 2003

Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes.  77:6533-6540. 2003

Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-Golgi network 46, and mannosidase II.  77:3191-3203. 2003

Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.  77:3229-3237. 2003

Role of the 5'-proximal stem-loop structure of the 5' untranslated region in replication and translation of hepatitis C virus RNA..  77:3312-3318. 2003

Foamy virus envelope glycoprotein is sufficient for particle budding and release.  77:2338-2348. 2003

Human cytomegalovirus infection leads to accumulation of geminin and inhibition of the licensing of cellular DNA replication.  77:2369-2376. 2003

The interaction between the major capsid protein and the smallest capsid protein of human cytomegalovirus is dependent on two linear sequences in the smallest capsid protein.  77:2730-2735. 2003

Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production.  76:12023-12031. 2002

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.  76:12900-12907. 2002

A P22 scaffold protein mutation increases the robustness of head assembly in the presence of excess portal protein..  76:10245-10255. 2002

Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.  76:8776-8786. 2002

Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.  76:8347-8359. 2002

Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.  76:8276-8284. 2002

Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: Pathogenesis.  76:7661-7671. 2002

Human immunodeficiency virus-specific CD8⁺ T cells in human breast milk.  76:7365-7373. 2002

Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.  76:7518-7527. 2002

Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro..  76:6900-6908. 2002

Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.  76:5692-5700. 2002

Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome.  76:5369-5379. 2002

Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.  76:4764-4772. 2002

Pathogenesis of avian influenza A (H5N1) viruses in ferrets.  76:4420-4429. 2002

The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.  76:4331-4340. 2002

Recombinant vaccinia virus-induced T-cell immunity: Quantitation of the response to the virus vector and the foreign epitope.  76:3329-3337. 2002

Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation.  76:2964-2972. 2002

Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication.  76:2973-2989. 2002

Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication..  76:2973-2989. 2002

Magnitude of functional CD8⁺ T-cell responses to the Gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.  76:2298-2305. 2002

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.  76:292-302. 2002

Cervicovaginal lamina propria lymphocytes: Phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.  76:9-18. 2002

Distribution of chemokine receptor ccr2 and ccr5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.  76:662-672. 2002

Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus.  76:1450-1460. 2002

Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection.  76:11254-11264. 2002

Second-site mutation outside of the Us10-12 domain of δγ134.5 Herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase r and partially restores neurovirulence.  76:942-949. 2002

Impairment of Gag-specific CD8⁺ T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.  75:11483-11495. 2001

Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.  75:11365-11372. 2001

Palmitoylation of the Rous sarcoma virus transmembrane glycoprotein is required for protein stability and virus infectivity.  75:11544-11554. 2001

Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.  75:11474-11482. 2001

Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.  75:10746-10754. 2001

Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy.  75:9493-9501. 2001

Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.  75:8681-8689. 2001

Human papillomavirus E6E7-mediated adenovirus cell killing: Selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.  75:7602-7611. 2001

p21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7.  75:6121-6134. 2001

In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2D^b but not H-2K^b.  75:5099-5107. 2001

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza a H5N1 virus infection.  75:5141-5150. 2001

Efficient translation initiation is required for replication of bovine viral diarrhea virus subgenomic replicons.  75:4226-4238. 2001

Identification of critical elements in the tRNA acceptor stem and TψC loop necessary for human immunodeficiency virus type 1 infectivity.  75:4902-4906. 2001

Immunity to influenza A H9N2 viruses induced by infection and vaccination.  75:4896-4901. 2001

Herpes simplex virus-induced keratitis: Evaluation of the role of molecular mimicry in lesion pathogenesis.  75:3077-3088. 2001

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.  75:3250-3258. 2001

Dissemination and pathology of simian immunodeficiency virus PBj14 early after rectal infection of pig-tailed macaques.  75:278-91. 2001

Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).  74:11881-11892. 2000

Infection of human dendritic cells by a Sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein.  74:11849-11857. 2000

Molecular correlates of influenza A H5N1 virus pathogenesis in mice.  74:10807-10810. 2000

Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation.  74:8335-8342. 2000

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.  74:8358-8367. 2000

Two putative α-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms.  74:7179-7186. 2000

A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G1 cell cycle arrest.  74:6058-6067. 2000

Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.  74:6105-6116. 2000

Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.  74:5495-5501. 2000

Protective immunity to rotavirus shedding in the absence of interleukin- 6: Th1 cells and immunoglobulin A develop normally.  74:5250-5256. 2000

Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-Golgi-intermediate compartment.  74:3842-3851. 2000

Identification of additional coat-scaffolding interactions in a bacteriophage P22 mutant defective in maturation.  74:3871-3873. 2000

The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association.  74:3761-3770. 2000

Characterization of the R572T point mutant of a putative cleavage site in human foamy virus env.  74:2949-2954. 2000

Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: Characterization of a potential site of virus assembly.  74:975-986. 2000

A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.  74:10249-10255. 2000

De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus..  74:851-863. 2000

Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 Tat in astrocytes.  74:9214-9221. 2000

Study of the assembly of vesicular stomatitis virus N protein: Role of the P protein.  74:9515-9524. 2000

pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion..  73:1785-1794. 1999

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.  73:5903-5911. 1999

An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes.  73:7210-7217. 1999

Genetic analysis of a unique human immunodeficiency virus type 1 (HIV- 1) with a primer binding site complementary to tRNA(Met) supports a role for U5-PBS stem-loop RNA structures in initiation of HIV-1 reverse transcription.  73:1818-1827. 1999

Human cytomegalovirus infection of Caco-2 cells occurs at the basolateral membrane and is differentiation state dependent.  73:4552-4560. 1999

Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.  73:2126-2135. 1999

Human papillomavirus DNA replication compartments in a transient DNA replication system.  73:1001-1009. 1999

Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells.  73:3854-3865. 1999

Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1.  73:8831-8836. 1999

Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes.  73:5026-5033. 1999

Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein transgene expression in human cells in vitro and murine tissues in vivo.  72:1593-1599. 1998

Adeno-associated virus type 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression.  72:9835-9843. 1998

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor- independent cell entry mechanism.  72:9706-9713. 1998

Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.  72:2483-2490. 1998

Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.  72:1844-1852. 1998

Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.  72:5472-5480. 1998

Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.  72:1552-1576. 1998

Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8⁺ cytotoxic T lymphocytes.  72:4534-4536. 1998

Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts.  72:3321-3329. 1998

Membrane organization of bluetongue virus nonstructural glycoprotein NS3.  72:3362-3369. 1998

Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3/(Lys) rather than tRNA1,2/(Lys).  72:5464-5471. 1998

Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes.  72:5224-5230. 1998

Retrovital recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation.  72:1195-1202. 1998

The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determines E2 protein specificity during DNA replication.  72:3436-3441. 1998

Transcription factor YY1 represses cell-free replication from human papillomavirus origins.  72:4911-4917. 1998

Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes.  72:749-757. 1998

Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus..  71:4062-4070. 1997

A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1.  71:5885-5893. 1997

A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.  71:778-784. 1997

Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats.  71:3077-3082. 1997

Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34⁺ hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation.  71:8262-8267. 1997

Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.  71:3098-3104. 1997

Encapsidation of adeno-associated virus type 2 rep proteins in wild- type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.  71:7361-7371. 1997

Glycoprotein H-related complexes of human cytomegalovirus: Identification of a third protein in the gCIII complex.  71:3090-3097. 1997

Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference.  71:6028-6036. 1997

Identification of a Sequence within U5 Required for Human Immunodeficiency Virus Type 1 to Stably Maintain a Primer Binding Site Complementary to tRNA^Met.  71:207-217. 1997

Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.  71:7704-7710. 1997

Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA.  71:6315-6322. 1997

Packaging Signals in Alohaviruses.  71:248-258. 1997

Role of sialyloligosaccharide binding in Theiler's virus persistence.  71:9701-9712. 1997

Sindbis virus replicons and sindbis virus: Assembly of chimeras and of particles deficient in virus RNA.  71:2819-2829. 1997

Transcription activities of human papillomavirus type 11 E6 promoter- proximal elements in raft and submerged cultures of foreskin keratinocytes.  71:8832-8840. 1997

Virus-specific, CD8⁺ major histocompatibility complex class I- restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus- infected β2-microglobulin-deficient mice.  71:8392-8396. 1997

A novel mechanism for persistence of human cytomegalovirus in macrophages.  70:1855-1862. 1996

Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA^His.  70:966-971. 1996

Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNAs.  70:1687-1694. 1996

Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2'-dideoxy-3'-thiacytidine by mutated M184V human immunodeficiency virus type 1.  70:5642-5645. 1996

Human cytomegalovirus (HCMV) smallest capsid protein identified as product of short open reading frame located between HCMV UL48 and UL49.  70:5680-5683. 1996

Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.  70:3378-3384. 1996

Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 gag.  70:2643-2649. 1996

Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions.  70:1668-1677. 1996

Translation of Sindbis virus mRNA: Analysis of sequences downstream of the initiating AUG codon that enhance translation.  70:1182-1190. 1996

Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.  69:1540-1547. 1995

An aspartic acid at amino acid 108 is required to rescue infectious virus after transfection of a poliovirus cDNA containing a CGDD but not SGDD amino acid motif in 3D(pol).  69:8173-8177. 1995

Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.  69:1359-1366. 1995

Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.  69:1548-1555. 1995

Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages.  69:3737-3743. 1995

Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H.  69:6047-6053. 1995

Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA3/(Lys).  69:6021-6029. 1995

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.  69:5228-5235. 1995

Mutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity.  69:1532-1539. 1995

Postoligomerization folding of human cytomegalovirus glycoprotein B: Identification of folding intermediates and importance of disulfide bonding.  69:7015-7022. 1995

Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.  69:3389-3398. 1995

The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.  69:7630-7638. 1995

Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.  69:8096-8101. 1995

Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4⁺ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein.  68:6863-6870. 1994

Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells.  68:1721-1727. 1994

Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.  68:1115-1127. 1994

In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: Comparison with the IRES of encephalomyocarditis virus.  68:1066-1074. 1994

Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.  68:6161-6169. 1994

Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.  68:1605-1614. 1994

The human poliovirus receptor alpha is a serine phosphoprotein.  68:6111-6115. 1994

Translation of sindbis virus mRNA: Effects of sequences downstream of the initiating codon.  68:8111-8117. 1994

A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.  67:4621-4629. 1993

Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.  67:3684-3690. 1993

Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 gag and pol proteins upon infection.  67:3712-3719. 1993

Enzymatic activity of poliovirus RNA polymerases with mutations at the tyrosine residue of the conserved YGDD motif: Isolation and characterization of polioviruses containing RNA polymerases with FGDD and MGDD sequences.  67:373-381. 1993

Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.  67:489-496. 1993

Poliovirus capsid proteins derived from P1 precursors with glutamine- valine cleavage sites have defects in assembly and RNA encapsidation.  67:7284-7297. 1993

Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes.  67:1721-1726. 1993

Sindbis virus expression vectors: Packaging of RNA replicons by using defective helper RNAs.  67:6439-6446. 1993

A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.  66:5290-5297. 1992

Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.  66:5224-5231. 1992

Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.  66:1129-1138. 1992

In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.  66:6806-6812. 1992

Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.  66:4556-4563. 1992

Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).  66:6747-6754. 1992

The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.  66:1303-1311. 1992

The nonmyristylated Pr160(gag-pol) polyprotein of human immunodeficiency virus type 1 interacts with Pr55(gag) and is incorporated into viruslike particles.  66:6304-6313. 1992

An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor..  65:3317-3329. 1991

An E1M E2C fusion protein encoded by human papillomavirus type 11 is a sequence-specific transcription repressor.  65:3317-3329. 1991

Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.  65:2088-2092. 1991

Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.  65:4555-4564. 1991

Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.  65:138-146. 1991

Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif.  65:4565-4572. 1991

Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.  65:2875-2883. 1991

Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes.  65:3973-3985. 1991

Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.  65:5111-5117. 1991

A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.  64:6176-6183. 1990

Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): Use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.  64:1079-1085. 1990

Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.  64:1808-1811. 1990

Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts.  64:3144-3149. 1990

Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice.  64:3310-3318. 1990

Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.  64:890-901. 1990

Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins.  64:5317-5323. 1990

Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne.  64:2922-2931. 1990

Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses.  63:4682-4688. 1989

Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.  63:1995-2001. 1989

Identification of a novel constitutive enhancer element and an associated binding protein: Implications for human papillomatovirus type 11 enhancer regulation.  63:2967-2976. 1989

Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding internalization, and neutralization of visna virus in macrophages.  63:1811-1813. 1989

Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.  63:403-410. 1989

Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIV(MAC).  62:3501-3505. 1988

Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).  62:3309-3318. 1988

Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: Functional and biochemical studies.  62:2994-3002. 1988

The putative trans-activator in the MA(gag) region of Rous sarcoma virus is not required for cell transformation.  62:4767-4769. 1988

Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.  61:2599-2606. 1987

Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata.  61:2581-2588. 1987

Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures.  61:1913-1918. 1987

Human cytomegalovirus virion-associated protein with kinase activity.  59:185-188. 1986

Isolation of mycoplasma virus L2 insertion variants and miniviruses.  59:584-590. 1986

Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.  58:185-191. 1986

Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus.  56:419-425. 1985

Identification of an enveloped phage, mycoplasma virus L172, that contains a 14-kilobase single-stranded DNA genome.  53:384-390. 1985

Morphogenesis of bacteriophage phi29 of Bacillus subtilis: Prohead restoration for DNA-gp3 packaging and assembly.  53:858-861. 1985

Partial nucleotide sequence of Rous sarcoma virus-29 provides evidence that the original Rous sarcoma virus was replication defective.  55:728-735. 1985

Purification of a soluble template-dependent rhinovirus RNA polymerase and its dependence on a host cell protein for viral RNA synthesis.  53:266-272. 1985

ATP is required for initiation of poliovirus RNA synthesis in vitro: Demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein.  50:515-523. 1984

Bacteriophage φ29 proteins required for in vitro DNA-gp3 packaging.  50:766-772. 1984

Amino-terminal amino acid sequence of p10, the fifth major gag polypeptide of avian sarcoma and leukemia viruses.  45:885-888. 1983

Antibody to a synthetic nonapeptide corresponding to the NH2 terminus of poliovirus genome-linked protein VPg reacts with native VPg and inhibits in vitro replication of poliovirus RNA.  48:429-439. 1983

Morphogenesis of bacteriophage φ29 of Bacillus subtilis: Oriented and quantized in vitro packaging of DNA protein gp3.  45:383-396. 1983

Morphogenesis of bacteriophage Φ29 of Bacillus subtilis: DNA-gp3 intermediate in in vivo and in vitro assembly.  41:508-517. 1982

Selective dansylation of M protein within intact influenza virions.  44:871-876. 1982

Comparison of late mRNA splicing among class B and class C adenoviruses.  30:899-912. 1979

Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products.  30:759-766. 1979